Evidence map›Paper›PMID 27423151›Full record

ArticleJournal of the American Association for Laboratory Animal Science : JAALAS2016

Pharmacokinetics of 2 Formulations of Transdermal Fentanyl in Cynomolgus Macaques (Macaca fascicularis).

Amy M Carlson, Richard Kelly, David P Fetterer, Pedro J Rico, Emily J Bailey

Open access · greenAbstract read
In one paragraph

Article in Journal of the American Association for Laboratory Animal Science : JAALAS, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed
2.2field-weighted citation impact, top 13% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed, 14 citations in OpenAlex.

  1. Pharmacokinetics of a Transdermal Fentanyl Solution in Suffolk Sheep (Journal of the American Association for Laboratory Animal Science : JAALAS · 2017
    Trial
  2. Article
  3. Article
  4. Review
  5. Article
  6. Evaluation of Analgesic Patches in Cynomolgus Macaques (Journal of the American Association for Laboratory Animal Science : JAALAS · 2019
    Article
  7. Pharmacokinetics of a Novel, Transdermal Fentanyl Solution in Rhesus Macaques (Journal of the American Association for Laboratory Animal Science : JAALAS · 2017
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 1 institution in 1 country.

Amy M CarlsonVeterinary Medicine Division, The United States Army Research Institute of Infectious Diseases, Fort Detrick, Maryland, USA. amy.m.carlson6.mil@mail.mil.
Richard KellyVeterinary Medicine Division, The United States Army Research Institute of Infectious Diseases, Fort Detrick, Maryland, USA.
David P FettererStatistics, The United States Army Research Institute of Infectious Diseases, Fort Detrick, Maryland, USA.
Pedro J RicoVeterinary Medicine Division, The United States Army Research Institute of Infectious Diseases, Fort Detrick, Maryland, USA.
Emily J BaileyVeterinary Medicine Division, The United States Army Research Institute of Infectious Diseases, Fort Detrick, Maryland, USA.
United States Army Medical Research Institute of Infectious Diseases · US

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Fentanyl is a μ-opioid agonist that often is used as the analgesic component for balanced anesthesia in both human and veterinary patients. Minimal information has been published regarding appropriate dosing, and the pharmacokinetics of fentanyl are unknown in NHP. The pharmacokinetic properties of 2 transdermal fentanyl delivery methods, a solution (2.6 and 1.95 mg/kg) and a patch (25 μg/h), were determined when applied topically to the dorsal scapular area of cynomolgus macaques (Macaca fascicularis). Serum fentanyl concentrations were analyzed by using liquid chromatography-mass spectrometry. Compared with the patch, the transdermal fentanyl solution generated higher drug concentrations over longer time. Adverse reactions occurred in the macaques that received the transdermal fentanyl solution at 2.6 mg/kg. Both preparations showed significant interanimal variability in the maximal serum drug levels, time to achieve maximal fentanyl levels, elimination half-life, and AUC values. Both the maximal concentration and the time at which this concentration occurred were increased in macaques compared with most other species after application of the transdermal fentanyl patch and compared with dogs after application of the transdermal fentanyl solution. The pharmacokinetic properties of transdermal fentanyl in macaques are markedly different from those in other veterinary species and preclude its use as a long-acting analgesic drug in NHP.

Indexed as

Administration, CutaneousAnalgesics, OpioidAnimalsChromatography, LiquidCross-Over StudiesFemaleFentanylHalf-LifeMacaca fascicularisMaleMass SpectrometryPilot ProjectsRandom AllocationAnalgesics, OpioidFentanyl

Identifiers

PMID27423151
PMCPMC4943615
OpenAlexW2510752523

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.